Rosenshein NB - Search Results

1

Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay.

Matsuo K, Bond VK, Im DD, Rosenshein NB. Matsuo K, et al. Among authors: rosenshein nb. Am J Clin Oncol. 2010 Aug;33(4):358-63. doi: 10.1097/COC.0b013e3181af30d3. Am J Clin Oncol. 2010. PMID: 19875949

2

Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas.

Matsuo K, Eno ML, Im DD, Rosenshein NB. Matsuo K, et al. Among authors: rosenshein nb. Arch Gynecol Obstet. 2010 Feb;281(2):325-8. doi: 10.1007/s00404-009-1121-1. Epub 2009 May 20. Arch Gynecol Obstet. 2010. PMID: 19455347

3

Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer.

Matsuo K, Bond VK, Eno ML, Im DD, Rosenshein NB. Matsuo K, et al. Among authors: rosenshein nb. Int J Cancer. 2009 Dec 1;125(11):2721-7. doi: 10.1002/ijc.24654. Int J Cancer. 2009. PMID: 19530239 Free article.

4

Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma.

Matsuo K, Eno ML, Im DD, Rosenshein NB, Sood AK. Matsuo K, et al. Among authors: rosenshein nb. Gynecol Oncol. 2010 Jan;116(1):61-5. doi: 10.1016/j.ygyno.2009.09.018. Epub 2009 Oct 17. Gynecol Oncol. 2010. PMID: 19840886 Free PMC article.

5

Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.

Matsuo K, Eno ML, Ahn EH, Shahzad MM, Im DD, Rosenshein NB, Sood AK. Matsuo K, et al. Among authors: rosenshein nb. Am J Clin Oncol. 2011 Oct;34(5):488-93. doi: 10.1097/COC.0b013e3181ec5f4b. Am J Clin Oncol. 2011. PMID: 20921883 Free PMC article.

6

Patient-reported symptoms and survival in ovarian cancer.

Matsuo K, Ahn EH, Prather CP, Eno ML, Im DD, Rosenshein NB. Matsuo K, et al. Among authors: rosenshein nb. Int J Gynecol Cancer. 2011 Dec;21(9):1555-65. doi: 10.1097/IGC.0b013e3182259c7f. Int J Gynecol Cancer. 2011. PMID: 21912266

7

Inferior vena cava filter placement and risk of hematogenous distant metastasis in ovarian cancer.

Matsuo K, Carter CM, Ahn EH, Prather CP, Eno ML, Im DD, Rosenshein NB. Matsuo K, et al. Among authors: rosenshein nb. Am J Clin Oncol. 2013 Aug;36(4):362-7. doi: 10.1097/COC.0b013e318248da32. Am J Clin Oncol. 2013. PMID: 22643565

8

Significance of lymphovascular space invasion in epithelial ovarian cancer.

Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, Rosenshein NB, Mabuchi S, Enomoto T, Kimura T, Sood AK, Roman LD. Matsuo K, et al. Among authors: rosenshein nb. Cancer Med. 2012 Oct;1(2):156-64. doi: 10.1002/cam4.31. Epub 2012 Sep 14. Cancer Med. 2012. PMID: 23342265 Free PMC article.

9

Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma.

Matsuo K, Sheridan TB, Mabuchi S, Yoshino K, Hasegawa K, Studeman KD, Im DD, Rosenshein NB, Roman LD, Sood AK. Matsuo K, et al. Among authors: rosenshein nb. Gynecol Oncol. 2014 Jun;133(3):473-9. doi: 10.1016/j.ygyno.2014.03.563. Epub 2014 Mar 25. Gynecol Oncol. 2014. PMID: 24674832 Free PMC article.

10

The use of paclitaxel and cisplatin in a patient with epithelial ovarian cancer and human immunodeficiency virus.

Knox SN, Robinson JB, Im DD, Logan L, Rosenshein NB. Knox SN, et al. Among authors: rosenshein nb. Gynecol Oncol. 2000 Jan;76(1):118-22. doi: 10.1006/gyno.1999.5590. Gynecol Oncol. 2000. PMID: 10620453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page